121,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
61 °P sammeln
  • Gebundenes Buch

All biomaterials and medical devices are subject to a long list of regulatory practises and policies which must be adhered to in order to receive clearance. This book provides readers with information on the systems in place in the USA and the rest of the world. Chapters focus on a series of procedures and policies including topics such as commercialization, clinical development, general good practise manufacturing and post market surveillance.

Produktbeschreibung
All biomaterials and medical devices are subject to a long list of regulatory practises and policies which must be adhered to in order to receive clearance. This book provides readers with information on the systems in place in the USA and the rest of the world. Chapters focus on a series of procedures and policies including topics such as commercialization, clinical development, general good practise manufacturing and post market surveillance.
Autorenporträt
Stephen Amato is a member of the faculty teaching in the Master of Science in Regulatory Affairs for Drugs, Biologics, and Medical Devices program at Northeastern University, Massachusetts. His research interests include U.S. and international product commercialization, FDA and global regulation, regulatory reimbursement, and the pricing of life sciences products. Bob Ezzell is a Graduate Instructor in Northeastern University's Regulatory Affairs Graduate Program, Massachusetts.